Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.

BACKGROUND Liver transplantation is a controversial issue in the initial management of hepatocellular carcinoma (HCC). The aim of this study was to demonstrate that up-to-seven could be useful as a model in evaluating potential candidates for liver transplantation for HCC. METHODS Between January 1997 and December 2010, 84 patients undergoing liver transplantation were analyzed for HCC. Pathologic variables included the number of lesions, maximal tumor diameter, vascular invasion, and tumor grade. The following variables were recorded: Age, gender, recurrence of HCC, survival, donor age, incidental, Milan criteria, Model for End-Stage Liver Disease score, and alpha-fetoprotein (AFP) levels. To evaluate variables we used the Kaplan-Meier method, Cox regression and Kolmogorov-Smirnov test. RESULTS There were 68 (80.9%) patients within up-to-seven criteria and 16 (19.1%) beyond this criteria. AFP levels were 96.4 versus 464.3 ng/dL in patients within versus beyond up-to-seven criteria. The median diameter of the largest nodule was 22.2 versus 32.0 mm in patients within versus beyond up-to-seven criteria, respectively. The median sum of nodules was 1.8 and 5.6 nodules in patients within versus beyond up-to-seven criteria. Vascular invasion was present in 11 (13.0%) patients within versus 7 (8.3%) beyond. Recurrence was observed in 9 (10.7%) patients and only 3 were beyond up-to-seven criteria, 2 had vascular invasion, and another showed poor differentiation. Post liver transplantation survival rates were 87.7%, 74.5%, and 65.3% at 1, 3, and 5 years in patients within up-to-seven versus 80.7%, 51.7%, and 32.1% beyond (P = .03). Similar results were observed when we applied Milan criteria or expanded Milan criteria. The largest nodule was the only predictive factor after proportional hazard Cox regression application (Beta = 0.037; exponent = 1.0377; Wald = 4.542; P = .03). In the present study, up-to-seven criteria could be useful to evaluate potential liver transplant candidates due to HCC.

[1]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[2]  I. Irlin,et al.  [EMBRYONAL SERUM ALPHA- GLOBULIN AND ITS SYNTHESIS BY TRANSPLANTABLE MOUSE HEPATOMAS]. , 1963, Biokhimiia.

[3]  M. Makuuchi,et al.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey , 2004, Cancer.

[4]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[5]  I. Dvorchik,et al.  Liver organ allocation for hepatocellular carcinoma: Are we sure? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  Y. Maehara,et al.  Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma , 2007, Transplantation.

[7]  I. Bilbao,et al.  Liver Transplantation for Malignant Diseases: Selection andPattern of Recurrence , 2002, World Journal of Surgery.

[8]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[9]  K. Ohnishi,et al.  Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha‐fetoprotein levels. Analysis of 606 patients , 1989, Cancer.

[10]  Abelev Gi,et al.  production Of Embryonal α-globulin By Transplantable Mouse Hepatomas , 1963 .

[11]  T. Schiano,et al.  Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up‐to‐seven criteria , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  K. Sung,et al.  Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  A. Gerbes,et al.  Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.